Regulatory

Best practices for clinical trial design to meet EFSA standards for scientific evidence. This means methodological honesty through clear hypotheses, proper controls, unbiased procedures, transparent reporting, and no manipulation of design or data to force an outcome.

In this interview, Laura Allred, PhD, regulatory manager at the Gluten Free Certification Organization (GFCO), discusses ongoing concerns around gluten-free oat safety and explains why third-party certification remains critical regardless of potential regulatory changes.

In this interview, Laura Allred, PhD, of the Gluten Free Certification Organization explains why GFCO requires products to test below 10 ppm of gluten while maintaining support for the FDA’s 20 ppm regulatory threshold, highlighting analytical variability in testing methods.

In this interview, Laura Allred, PhD, regulatory manager at the Gluten Free Certification Organization (GFCO), discusses the U.S. Food and Drug Administration’s recent Request for Information on gluten labeling in packaged foods, highlighting key gaps in current regulations, including rye and barley labeling and oat safety.

The US Food and Drug Administration is gathering data on gluten-related labeling concerns, including cross-contamination, as part of a broader effort to improve transparency on packaged food ingredients.

The legislation would require supplement companies to registry product information that would be then made public on an online database. Advocates argue that a mandatory product registry would offer greater transparency and allow regulators to be more effective in their enforcement.

Inside FDA’s VQIP, the program that expedites entry for proven, low-risk importers.

FDA clarifies how the DSHEA disclaimer must appear on dietary supplement labels, signaling flexibility on placement and enforcement discretion.

Nutritional Outlook's 2025 Best of the Industry—Industry Leader, Jim Emme, CEO of NOW Health Group and Chair of the Natural Products Association’s Board of Directors, is an influential voice that helps call attention to bad actors and engages with our country’s leaders, all while leading a successful and respected dietary supplement brand.

How to design a study so that it passes EFSA's appraisal of biological relevance.

The Senate’s reopening the government bill has passed but it includes a section that redefines hemp and can ban hemp products with a greater amount of 0.4 mg total THC.

The court of appeals has denied the Council for Responsible Nutrition's appeal seeking a preliminary injunction against New York's law banning the sale of weight management supplements to minors. The association's lawsuit endures.

The new certification program is conducted in partnership with TruShield Certified.

While California Senate Bill 646 threatens to hurt the reputation of prenatal supplements, clarifying language in S.B. 862 prevents onerous testing and disclosure requirements for supplements.

In its response to the citizen petitions, FDA has reversed its stance that NMN was not a dietary ingredient.

At CRN Convergence 2025, FDA Deputy Commissioner Diamantas will discuss Human Foods Program priorities, supplement regulations, and industry trends, joining keynote speakers Jim VandeHei and Dr. Daniel Kraft at the event.

The systematic review from AHRQ did not find a large body of evidence to suggest omega-3 intakes confer demonstrable advantages, and that there is too much heterogeneity and bias in the existing literature.

The MAHA report outlines more than 120 initiatives to fight childhood chronic disease in the US through nutrition, research, and policy reform.

Citing risks to public health, Governor Mike DeWine called upon the Ohio Board of Pharmacy to designate kratom compounds as illegal drugs, though a meeting on the placement was recently canceled.

NutriLeads submitted an application for their precision prebiotic Benicaros SF Pure P product to receive formal authorization, where the EFSA’s opinion deemed the carrot pomace-derived ingredient safe for human consumption.

The plant-based, beauty-from-within ingredient has been demonstrated to support skin health and anti-aging potential.

What food and dietary supplement brands need to know about extended producer responsibility (EPR).

The excipient has been used for pigment and opacity in a large number of medicinal products.

FDA Commissioner praises Florida’s emergency rule, following calls to place the compound known as hydroxymitragynine (7-OH) under the Controlled Substances Act

Working together to ensure food safety, AOAC International and the USDA FSIS have signed a Memorandum of Agriculture.

FDA has sent seven warning letters to companies illegally marketing products containing synthetic 7-hydroxymitragynine (7-OH), a chemical compound found in kratom.

FDA grants color additive petition for gardenia (genipin) blue, making it the fourth naturally-derived color additive approved since the agency announced plans to phase out FD&C colors.

NOW recently disclosed that the company has expanded their ISO17025 chemical and biological field scopes accreditation.